Company profile
Recursion Pharmaceuticals, Inc. Insider Trading
RXRXEvery SEC Form 4 insider trading filing for Recursion Pharmaceuticals, Inc. (RXRX) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001601830
- Filings
- 303
- Insiders
- 18
- Last filing
- 2026-09-15
Activity summary
Recent insider activity is bearish. Over the last 30 days, insiders net sold $18K across 1 transaction.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Recursion Pharmaceuticals, Inc. insiders were net sellers in every quarter shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $6.5M.
90 day insight
Over the last 90 days, Recursion Pharmaceuticals, Inc. insiders bought $0 (2 transactions) and sold $436K (4 transactions).
- Most active insider: Blake Borgeson with 3 transactions totaling $356K.
- Largest single sale: $254K by Najat Khan on Aug 17, 2026.
- 50% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bearish — sales outpace buys.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Ben R Taylor | RXRX | Tax Withholding | 5,396 | $3.41 | $18K |
| Sep 8, 2026 | Najat Khan | RXRX | Sale10b5 | 22,408 | $3.52 | $79K |
| Sep 1, 2026 | Blake Borgeson | RXRX | Sale10b5 | 30,000 | $3.34 | $100K |
| Aug 17, 2026 | David Hallett | RXRX | Tax Withholding | 26,657 | $3.16 | $84K |
| Aug 17, 2026 | Ben R Taylor | RXRX | Tax Withholding | 25,018 | $3.16 | $79K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=RXRX" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Recursion Pharmaceuticals, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →